Steroid 5 alpha reductase (SR) is rate-limiting enzyme of one of two major metabolic pathways in brain steroidogenesis. Recent evidence indicates that neuroactive steroids may involved in pathogenesis of schizophrenia spectrum disorders. Moreover, SR inhibition has been shown to induce therapeutic effects in animal models of schizophrenia and in several disorders associated to dopaminergic hyperreactivity. In rodents, sleep deprivation (SD) is known to induce a series of behavioural patterns, including sensory-motor gating deficit, which might be reflective of psychosis and mania and are countered by antipsychotics. The aim of this study was to evaluate, the impact of SD on expression levels of SR isozymes in rat brain. After 72 h of SD, rats were sacrificed and brain areas dissected out. Quantitative 1D and 2D western blotting (WB) with antibodies were performed on four brain areas of both control group and SD group (n = 8 each): medial prefrontal cortex (mPFC), nucleus accumbens (nACC), ippocampus (IPPO) and amigdala (AMG). 1D and 2D WB revealed that the expression of SR-1 and SR-2 was significantly augmented in SD animals in comparison to controls (p < 0.05) in mPFC and nACC area. In IPPO and AMG expression of SR-1 and SR-2 was unchanged in SD animals in comparison to controls. Regarding therapeutic effect of SR inhibition on gating deficit, data suggest that SR increase might cause altered balancing in neurosteroid levels, and it could be responsible of behavioral disruption observed in SD animals.
Proteomic profiling of brain steroid 5 alpha reductases in sleep-deprivated rats / A. Soggiu, M. Bortolato, P. Devoto, C. Piras, L. Bonizzi, P. Roncada. ((Intervento presentato al 6. convegno ItPA Annual National Conference tenutosi a Torino nel 2011.
Proteomic profiling of brain steroid 5 alpha reductases in sleep-deprivated rats
A. SoggiuPrimo
;C. Piras;L. BonizziPenultimo
;P. RoncadaUltimo
2011
Abstract
Steroid 5 alpha reductase (SR) is rate-limiting enzyme of one of two major metabolic pathways in brain steroidogenesis. Recent evidence indicates that neuroactive steroids may involved in pathogenesis of schizophrenia spectrum disorders. Moreover, SR inhibition has been shown to induce therapeutic effects in animal models of schizophrenia and in several disorders associated to dopaminergic hyperreactivity. In rodents, sleep deprivation (SD) is known to induce a series of behavioural patterns, including sensory-motor gating deficit, which might be reflective of psychosis and mania and are countered by antipsychotics. The aim of this study was to evaluate, the impact of SD on expression levels of SR isozymes in rat brain. After 72 h of SD, rats were sacrificed and brain areas dissected out. Quantitative 1D and 2D western blotting (WB) with antibodies were performed on four brain areas of both control group and SD group (n = 8 each): medial prefrontal cortex (mPFC), nucleus accumbens (nACC), ippocampus (IPPO) and amigdala (AMG). 1D and 2D WB revealed that the expression of SR-1 and SR-2 was significantly augmented in SD animals in comparison to controls (p < 0.05) in mPFC and nACC area. In IPPO and AMG expression of SR-1 and SR-2 was unchanged in SD animals in comparison to controls. Regarding therapeutic effect of SR inhibition on gating deficit, data suggest that SR increase might cause altered balancing in neurosteroid levels, and it could be responsible of behavioral disruption observed in SD animals.Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.